Clinical equivalence of a new glucocorticoid, deflazacort and prednisone in rheumatoid arthritis and S.L.E. patients
Imbimbo, B.; Tuzi, T.; Porzio, F.; Schiavetti, L.
Advances in Experimental Medicine and Biology 171: 241-256
1984
ISSN/ISBN: 0065-2598 PMID: 6372394 Document Number: 222767
Document emailed within 1 workday
Related Documents
Ferrari, A.; Pasqualetti, D.; Del Bianco, P.; Gandolfo, G.M.; Chistolini, A.; Mazzucconi, M.G. 1991: Prednisone versus deflazacort in the treatment of autoimmune thrombocytopenic purpura: evaluation of clinical response and immunological modifications Haematologica 76(4): 342-345Buttgereit, F.; Kent, J.D.; Holt, R.J.; Grahn, A.Y.; Rice, P.; Alten, R.; Yazici, Y. 2015: Improvement Thresholds for Morning Stiffness Duration in Patients Receiving Delayed- Versus Immediate-Release Prednisone for Rheumatoid Arthritis Bulletin of the Hospital for Joint Disease 73(3): 168-177
Eggert, M.; Klüter, A.; Rusch, D.; Schmidt, K.L.; Dotzlaw, H.; Schulz, M.; Pabst, W.; Böke, J.ör.; Renkawitz, R.; Neeck, G. 2002: Expression analysis of the glucocorticoid receptor and the nuclear factor-kB subunit p50 in lymphocytes from patients with rheumatoid arthritis Journal of Rheumatology 29(12): 2500-2506
Cortet, B.; Flipo, R.M.; Blanckaert, F.; Duquesnoy, B.; Marchandise, X.; Delcambre, B. 1997: Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy Revue du Rhumatisme 64(7-9): 451-458
Satoh, M.; Ajmani, A.K. 1993: Acute exacerbation mimicking "pseudoseptic" arthritis in rheumatoid arthritis could be caused by abrupt discontinuation of glucocorticoid Journal of Rheumatology 20(8): 1441-1442
Lange, U.; Illgner, U.; Teichmann, J.; Schleenbecker, H. 2004: Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study International Journal of Clinical Pharmacology Research 24(2-3): 33-38
Mazzucconi, M.G.; Malagnino, F.; De Laurentis, C.; Criscuolo, D. 1980: Deflazacort in thrombocytopenia: a comparison with prednisone International Journal of Clinical Pharmacology Therapy and Toxicology 18(12): 538-542
Krogsgaard, M.R.; Thamsborg, G.; Lund, B. 1997: Bone loss during low dose glucocorticoid treatment in patients with polymyalgia rheumatica. a double-blind, prospective comparison between prednisolone and deflazacort Ugeskrift for Laeger 159(30): 4641-4644
Criswell, L.A.; Henke, C.J. 1995: What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis? Journal of Rheumatology 22(5): 829-835
Trèves, R. 1995: Low-dose glucocorticoid therapy in rheumatoid arthritis Revue du Rhumatisme 62(10): 611-617
Townsend, H.B.; Saag, K.G. 2004: Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks Clinical and Experimental Rheumatology 22(5 Suppl 35: S77-S82
Paulus, H.E.; Ramos, B.; Wong, W.K.; Ahmed, A.; Bulpitt, K.; Park, G.; Sterz, M.; Clements, P. 1999: Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists Journal of Rheumatology 26(11): 2324-2331
Tokano, Y.; Hashimoto, H.; Okumura, Y.; Hirose, S. 1988: Expanded clinical and basic profile of rheumatoid factors. 2. Analysis of IgG in normal subjects and patients with rheumatoid arthritis using nuclear magnetic resonance Ryumachi 28(6): 416-419
Chapela, R. 1995: Comparative study of the effectiveness of 2 oral corticoids in the control of severe crisis of bronchial asthma: deflazacort and prednisone Revista Alergia Mexico 42(4): 64-68
Masi, A.T.; Chrousos, G.P.; Bornstein, S.R. 1999: Enigmas of adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis Journal of Rheumatology 26(2): 247-250
Salaffi, F.; Migliore, A.; Scarpellini, M.; Corsaro, S.M.; Laganà, B.; Mozzani, F.; Varcasia, G.; Pusceddu, M.; Pomponio, G.; Romeo, N.; Maier, A.; Foti, R.; Scarpa, R.; Gasparini, S.; Bombardieri, S. 2010: Psychometric properties of an index of three patient reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study Clinical and experimental rheumatology 28(2): 186-200
Criswell, L.A.; Such, C.L.; Yelin, E.H. 1997: Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists Journal of Rheumatology 24(12): 2283-2290
Bird, H.A.; Hill, J.; Dixon, J.S.; Bojar, R.; Traficante, A.; Catalano, M.A.; Adair, S.F.; Liauw, L.; Sussman, H.; Rotman, H. 1989: A clinical and biochemical assessment of prinomide in patients with rheumatoid arthritis Journal of Rheumatology 16(4): 448-454
Rodriguez, M.A.; Bravo, J.R.; Armas, P.; Contreras, C.E.; Perez-Rojas, G.; Bianco, N. 1984: Immune complexes and clinical manifestations in patients with rheumatoid arthritis Journal of Rheumatology 11(2): 245-246
Yu, C.; Li, M.; Duan, X.; Fang, Y.; Li, Q.; Wu, R.; Liu, S.; Wang, Y.; Wu, Z.; Shi, X.; Jiang, Z.; Wang, Y.; Hsieh, E.D.; Jin, S.; Jiang, N.; Wang, Q.; Zhao, Y.; Tian, X.; Zeng, X. 2018: Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis Clinical and Experimental Rheumatology 36(5): 836-840